-
公开(公告)号：US20090324535A1
公开(公告)日：2009-12-31
申请号：US12161688
申请日：2006-05-15
申请人： Benjamin James Boyd , Lisa Michelle Kaminskas , Christopher John Hamilton Porter , Peter Karellas , Guy Yeoman Krippner , Pasquale Razzino , Brian Devlin Kelly , Zemin Wu , Sue Pallich
发明人： Benjamin James Boyd , Lisa Michelle Kaminskas , Christopher John Hamilton Porter , Peter Karellas , Guy Yeoman Krippner , Pasquale Razzino , Brian Devlin Kelly , Zemin Wu , Sue Pallich
IPC分类号： A61K47/48 , C08F283/06 , A61K38/10 , A61K38/16
CPC分类号： C08G65/33396 , A61K31/74 , A61K31/785 , A61K47/59 , A61K47/595 , A61K47/60 , A61K47/645 , C08G69/10 , C08G83/003
摘要： The present invention relates to a macromolecule having a controlled terminal group stoichiometry, the macromolecule including a surface layer, at least one subsurface layer and at least two terminal groups including: a first terminal group which is a residue of a pharmaceutically active agent, a derivative thereof or precursor therefor; and a second terminal group selected to modify the pharmacokinetics of the pharmaceutically active agent and/or macromolecule, wherein terminal group stoichiometry refers to the number and type of terminal groups.
摘要翻译： 本发明涉及具有受控终端基团化学计量的大分子，所述高分子包括表面层，至少一个地下层和至少两个末端基团，所述末端基团包括：第一末端基团，其为药物活性剂的残基，衍生物 或其前体; 和选择用于改变药物活性剂和/或大分子的药代动力学的第二末端基团，其中末端基团化学计量指的是末端基团的数量和类型。
-
公开(公告)号：US08337823B2
公开(公告)日：2012-12-25
申请号：US12161688
申请日：2006-05-15
申请人： Benjamin James Boyd , Lisa Michelle Kaminskas , Christopher John Hamilton Porter , Peter Karellas , Guy Yeoman Krippner , Brian Devlin Kelly , Zemin Wu , Pasquale Razzino , Sue Pallich
发明人： Benjamin James Boyd , Lisa Michelle Kaminskas , Christopher John Hamilton Porter , Peter Karellas , Guy Yeoman Krippner , Brian Devlin Kelly , Zemin Wu , Pasquale Razzino , Sue Pallich
CPC分类号： C08G65/33396 , A61K31/74 , A61K31/785 , A61K47/59 , A61K47/595 , A61K47/60 , A61K47/645 , C08G69/10 , C08G83/003
摘要： The present invention relates to a macromolecule having a controlled terminal group stoichiometry, the macromolecule including a surface layer, at least one subsurface layer and at least two terminal groups including: a first terminal group which is a residue of a pharmaceutically active agent, a derivative thereof or precursor therefor; and a second terminal group selected to modify the pharmacokinetics of the pharmaceutically active agent and/or macromolecule, wherein terminal group stoichiometry refers to the number and type of terminal groups.
摘要翻译： 本发明涉及具有受控终端基团化学计量的大分子，所述高分子包括表面层，至少一个地下层和至少两个末端基团，所述末端基团包括：第一末端基团，其为药物活性剂的残基，衍生物 或其前体; 和选择用于修饰药物活性剂和/或大分子的药代动力学的第二末端基团，其中末端基团化学计量指的是末端基团的数量和类型。
-
公开(公告)号：US20120302730A1
公开(公告)日：2012-11-29
申请号：US13570058
申请日：2012-08-08
申请人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
发明人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
CPC分类号： C08G83/003 , A61K31/785
摘要： The following invention is directed to macromolecules having controlled stoichiometry and topology, processes for their production, and applications for their use. The macromolecules have a controlled functional moiety stoichiometry and include at least one dendritic motif having a surface layer formed from at least one surface building unit and at least one subsurface layer formed from at least one building unit, the surface building unit and building units having a hydrocarbon backbone bearing a carbonyl group and at least one amine group; and at least two different functional moieties on the building unit and/or surface building unit; where functional moiety stoichiometry refers to the number and type of functional moieties.
摘要翻译： 以下发明涉及具有受控化学计量和拓扑结构的大分子，其生产方法及其应用。 大分子具有受控的功能部分化学计量学，并且包括至少一个树突状基序，其具有由至少一个表面构建单元形成的表面层和由至少一个建筑单元形成的至少一个地下层，所述表面建筑单元和建筑单元具有 具有羰基和至少一个胺基的烃主链; 和建筑物单元和/或表面建筑单元上的至少两个不同的功能部分; 功能部分化学计量指功能部分的数量和类型。
-
公开(公告)号：US08586705B2
公开(公告)日：2013-11-19
申请号：US13570058
申请日：2012-08-08
申请人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
发明人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
CPC分类号： C08G83/003 , A61K31/785
摘要： The following invention is directed to macromolecules having controlled stoichiometry and topology, processes for their production, and applications for their use. The macromolecules have a controlled functional moiety stoichiometry and include at least one dendritic motif having a surface layer formed from at least one surface building unit and at least one subsurface layer formed from at least one building unit, the surface building unit and building units having a hydrocarbon backbone bearing a carbonyl group and at least one amine group; and at least two different functional moieties on the building unit and/or surface building unit; where functional moiety stoichiometry refers to the number and type of functional moieties.
摘要翻译： 以下发明涉及具有受控化学计量和拓扑结构的大分子，其生产方法及其应用。 大分子具有受控的功能部分化学计量学，并且包括至少一个树突状基序，其具有由至少一个表面构建单元形成的表面层和由至少一个建筑单元形成的至少一个地下层，所述表面建筑单元和建筑单元具有 具有羰基和至少一个胺基的烃主链; 和建筑物单元和/或表面建筑单元上的至少两个不同的功能部分; 功能部分化学计量指功能部分的数量和类型。
-
公开(公告)号：US08258259B2
公开(公告)日：2012-09-04
申请号：US12091233
申请日：2006-10-25
申请人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
发明人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
CPC分类号： C08G83/003 , A61K31/785
摘要： The following invention is directed to macromolecules having controlled stoichiometry and topology, processes for their production, and applications for their use. The macromolecules have a controlled functional moiety stoichiometry and include at least one dendritic motif having a surface layer formed from at least one surface building unit and at least one subsurface layer formed from at least one building unit, the surface building unit and building units having a hydrocarbon backbone bearing a carbonyl group and at least one amine group; and at least two different functional moieties on the building unit and/or surface building unit; where functional moiety stoichiometry refers to the number and type of functional moieties.
摘要翻译： 以下发明涉及具有受控化学计量和拓扑结构的大分子，其生产方法及其应用。 大分子具有受控的功能部分化学计量学，并且包括至少一个树突状基序，其具有由至少一个表面构建单元形成的表面层和由至少一个建筑单元形成的至少一个地下层，所述表面建筑单元和建筑单元具有 具有羰基和至少一个胺基的烃主链; 和建筑物单元和/或表面建筑单元上的至少两个不同的功能部分; 功能部分化学计量指功能部分的数量和类型。
-
公开(公告)号：US20090118467A1
公开(公告)日：2009-05-07
申请号：US12091233
申请日：2006-10-25
申请人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
发明人： Guy Yeoman Krippner , Gottfried Lichti , Pasquale Razzino , Brian Devlin Kelly , Susanne Pallich , Scott Andrew Henderson , Angela Michelle Scheppokat , Charlotte Claire Williams , Christopher John Hamilton Porter , Benjamin James Boyd , Lisa Michelle Kaminskas , Phillip Martin Rendle , Ben William Greatrex
IPC分类号： C07K5/00
CPC分类号： C08G83/003 , A61K31/785
摘要： The following invention is directed to macromolecules having controlled stoichiometry and topology, processes for their production, and applications for their use. The macromolecules have a controlled functional moiety stoichiometry and include at least one dendritic motif having a surface layer formed from at least one surface building unit and at least one subsurface layer formed from at least one building unit, the surface building unit and building units having a hydrocarbon backbone bearing a carbonyl group and at least one amine group; and at least two different functional moieties on the building unit and/or surface building unit; where functional moiety stoichiometry refers to the number and type of functional moieties.
摘要翻译： 以下发明涉及具有受控化学计量和拓扑结构的大分子，其生产方法及其应用。 大分子具有受控的功能部分化学计量学，并且包括至少一个树突状基序，其具有由至少一个表面构建单元形成的表面层和由至少一个建筑单元形成的至少一个地下层，所述表面建筑单元和建筑单元具有 具有羰基和至少一个胺基的烃主链; 和建筑物单元和/或表面建筑单元上的至少两个不同的功能部分; 功能部分化学计量指功能部分的数量和类型。
-
公开(公告)号：US20120316146A1
公开(公告)日：2012-12-13
申请号：US13574201
申请日：2011-01-19
IPC分类号： A61K31/56 , A61P25/20 , A61P23/00 , A61K31/57 , A61K31/573
CPC分类号： A61K47/40 , A61K31/56 , A61K31/57 , A61K31/573 , A61K47/6951 , B82Y5/00
摘要： The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are provided in the form of host/guest preparations comprising one or more neuroactive steroid anaesthetics and a cyclodextrin. Particular cyclodextrins contemplated include sulfoalkyl ether cyclodextrins and modified forms thereof.
摘要翻译： 本发明一般涉及用于神经活性类固醇麻醉剂的药物递送系统领域。 更具体地，以包含一种或多种神经活性类固醇麻醉剂和环糊精的宿主/客体制剂的形式提供麻醉剂和镇静剂制剂。 预期的具体环糊精包括磺基烷基醚环糊精及其修饰形式。
-
公开(公告)号：US08697678B2
公开(公告)日：2014-04-15
申请号：US13574201
申请日：2011-01-19
IPC分类号： A61K31/56
CPC分类号： A61K47/40 , A61K31/56 , A61K31/57 , A61K31/573 , A61K47/6951 , B82Y5/00
摘要： The present invention relates generally to the field of drug delivery systems for neuroactive steroid anaesthetic agents. More particularly, anaesthetic and sedative formulations are provided in the form of host/guest preparations comprising one or more neuroactive steroid anaesthetics and a cyclodextrin. Particular cyclodextrins contemplated include sulfoalkyl ether cyclodextrins and modified forms thereof.
摘要翻译： 本发明一般涉及用于神经活性类固醇麻醉剂的药物递送系统领域。 更具体地，以包含一种或多种神经活性类固醇麻醉剂和环糊精的宿主/客体制剂的形式提供麻醉剂和镇静剂制剂。 预期的具体环糊精包括磺基烷基醚环糊精及其修饰形式。
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.046 秒)
